Regulatory Status Is Not an Endorsement — Or a Verdict
Approval for one indication says nothing about a second. Absence of approval says nothing about mechanism. Both errors are common.
Tesamorelin is approved to reduce excess visceral fat in adults with HIV-associated lipodystrophy. That approval is specific, evidence-based, and frequently cited to imply something it does not support: general body composition benefit in healthy adults.
The opposite error is equally common. A compound in phase 2 trials is not disproven; it is unproven.
Reading a status badge
Every compound page here shows a regulatory status alongside an evidence grade, because they answer different questions. Approved for a specific indication is a distinct status from approved, and we label it separately for that reason.
This article is educational and is not medical advice. It does not recommend or provide individualised dosing. Speak with a qualified healthcare professional about your own health.